IPP Bureau

President of India confers Padma Shri Award on Dr. P. Vijay Anand Reddy
President of India confers Padma Shri Award on Dr. P. Vijay Anand Reddy

By IPP Bureau - May 26, 2026

The director of Apollo Cancer Centres in Hyderabad and founder of CURE Foundation honored for his contributions to cancer awareness and treatment

Dr. Ramesh Juneja joins  Alembic Pharmaceuticals as Head – India Business
Dr. Ramesh Juneja joins Alembic Pharmaceuticals as Head – India Business

By IPP Bureau - May 26, 2026

With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses

Amgen appoints Madhur Sarin as Director – AI & Data Science COE
Amgen appoints Madhur Sarin as Director – AI & Data Science COE

By IPP Bureau - May 26, 2026

Sarin will focus on advancing scalable AI-driven platforms and strengthening the company’s global data science capabilities across healthcare and enterprise technology domains

Cornerstone Robotics secures EU CE mark and Singapore HSA approval for Sentire Surgical System
Cornerstone Robotics secures EU CE mark and Singapore HSA approval for Sentire Surgical System

By IPP Bureau - May 26, 2026

Dual regulatory clearances for Sentire(R) Endoscopic surgical system strengthen the company’s expansion across Europe and Asia-Pacific in minimally invasive robotic surgery

Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment
Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment

By IPP Bureau - May 25, 2026

The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026

Datroway wins US nod in aggressive breast cancer subtype
Datroway wins US nod in aggressive breast cancer subtype

By IPP Bureau - May 25, 2026

Clearance marks major shift beyond chemotherapy

Oral GLP-1 race heats up as Lilly’s Foundayo shines in seniors
Oral GLP-1 race heats up as Lilly’s Foundayo shines in seniors

By IPP Bureau - May 25, 2026

The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks

AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment
AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment

By IPP Bureau - May 25, 2026

If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections

WHO declares Ebola outbreak, Indians advised against travel to affected regions
WHO declares Ebola outbreak, Indians advised against travel to affected regions

By IPP Bureau - May 25, 2026

No approved vaccine or specific treatment currently available for Bundibugyo strain Ebola disease

Anupam Rasayan to acquire 43.3%–48.2% equity stake in Bliss GVS Pharma
Anupam Rasayan to acquire 43.3%–48.2% equity stake in Bliss GVS Pharma

By IPP Bureau - May 25, 2026

The acquisition marks Anupam Rasayan’s strategic entry into the pharmaceutical formulations segment

SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth
SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth

By IPP Bureau - May 25, 2026

Revenue from operations climbed 13% to Rs. 886.87 crore

Akumentis Healthcare appoints Dharnendra Doshi as Senior Vice President
Akumentis Healthcare appoints Dharnendra Doshi as Senior Vice President

By IPP Bureau - May 25, 2026

Veteran consumer health and FMCG strategist to lead preventive wellness and nutrition portfolio expansion through innovation and modern trade channels

AstraZeneca breast cancer drug wins key EU backing after cutting progression risk by 56%
AstraZeneca breast cancer drug wins key EU backing after cutting progression risk by 56%

By IPP Bureau - May 25, 2026

The recommendation is powered by blockbuster results from the pivotal Phase III SERENA-6 trial

Zota Health Care posts 83.86% revenue surge in FY26
Zota Health Care posts 83.86% revenue surge in FY26

By IPP Bureau - May 25, 2026

Expands Davaindia network to 2,579 stores

EMA accepts filing for Teva and Medincell’s long-acting schizophrenia treatment candidate
EMA accepts filing for Teva and Medincell’s long-acting schizophrenia treatment candidate

By IPP Bureau - May 25, 2026

If approved, TEV-‘749 would mark a shift toward long-acting care aimed at improving treatment adherence in real-world settings

Latest Stories

Interviews

Packaging